Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SSTR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
STK33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BICD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPEG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WT1-AS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
STK32A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THEMIS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C17orf51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL23R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNJ2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CTAG1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53I11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on